The American Journal of Managed Care

New Multiple Myeloma Drug Interferes With Routine Testing Prior to a Transfusion

A letter published in The New England Journal of Medicine provides narrative of a clinical interference that has been documented with the much hailed multiple myeloma drug daratumumab. A letter ...
Monthly Prescribing Reference

First Gene-Based Test to Determine RBC Types for Transfusion

The FDA has approved BioArray Solution’s Immucor PresciseType Human Erythrocyte Antigen (HEA) Molecular BeadChip Test, the first molecular assay used in transfusion medicine to determine blood ...
Monthly Prescribing Reference

FDA Approves New DNA-Based Test to Verify Blood Compatibility

If blood with poorly matched antibodies is transfused, the procedure is more likely to lead to red blood cell destruction and a transfusion reaction, the agency explained. HealthDay News — The US Food ...
Healio

Whole genome-based antigen testing may improve transfusion outcomes

A whole genome-based approach to antigen matching of patients with blood donors may represent a novel method to improve blood transfusion outcomes, according to study results published in The Lancet ...